Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amgen’s KRAS Inhibitor Shows Durability; Pivotal Data Possible This Year
Ongoing Phase II Study Could Support Accelerated Approval
Sep 22 2020
•
By
Mandy Jackson
To date, sotorasib monotherapy works best in lung cancer • Source: Shutterstock
More from Clinical Trials
More from R&D